ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e06f62b789c4232b
Product Name: ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
Artg Id: 408212
Artg Name: ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-06-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REP
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a14b2da536d2098f33a886680798a55e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/01cbd48b77fa74e2242b0562e15691e6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e06f62b789c4232b

Type

Standard